便検査の世界市場 2024-2028

Global Stool Testing Market 2024-2028

便検査の世界市場 2024-2028 便検査市場は、2023年から2028年にかけて4億4595万米ドルの成長が予測され、予測期間中のCAGRは5.92%で加速すると予測されます。この調査レポートは、便検査市場の全体的な分析、市... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
TechNavio テクナビオ	2023年10月31日	US$2,500 シングルユーザライセンスライセンス・価格情報注文方法はこちら	165	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

便検査の世界市場 2024-2028
便検査市場は、2023年から2028年にかけて4億4595万米ドルの成長が予測され、予測期間中のCAGRは5.92%で加速すると予測されます。この調査レポートは、便検査市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、好意的な取り組みや消化器疾患の有病率の増加、医療機関によるガイドラインの増加、CRCの有病率の増加によって牽引されています。
Technavioの便検査市場は以下のように区分されます：
タイプ別
- 消化管
- 便潜血
エンドユーザー別
- 病院
- 診断センターおよび検査室
- クリニック、その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の便検査市場の成長を促進する主な理由の1つとして、新興市場における高い成長可能性を挙げている。また、ポイントオブケア検査への需要の高まりと、CRCスクリーニングのための便潜血検査における技術的進歩は、市場の大きな需要につながる。
便検査市場に関するレポートは以下の分野をカバーしています：
- 便検査市場のサイジング
- 便検査市場の予測
- 便検査市場の産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、AdvaCare Pharma社、bioMerieux SA社、Cardinal Health Inc社、Cenogenics Corp社、Danaher Corp社、DiaSorin SpA社、Eiken Chemical Co.Ltd.、Epitope Diagnostics Inc.、Exact Sciences Corp.、Genova Diagnostics Inc.、Helena Laboratories Corp.、Hologic Inc.、McKesson Corp.、Meridian Bioscience Inc.、Pinnacle BioLabs、Polymedco CDP LLC、Quest Diagnostics Inc.、Quidelortho Corp.、CTK Biotech Inc.、ScheBo Biotech AG。また、便検査市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/stool-testing-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global stool testing market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global stool testing market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 GI - Market size and forecast 2023-2028
o Exhibit 34: Chart on GI - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on GI - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on GI - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on GI - Year-over-year growth 2023-2028 (%)
o 6.4 Fecal occult - Market size and forecast 2023-2028
o Exhibit 38: Chart on Fecal occult - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Fecal occult - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Fecal occult - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Fecal occult - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 7.4 Diagnostic centres and laboratories - Market size and forecast 2023-2028
o Exhibit 52: Chart on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
o 7.5 Clinics and others - Market size and forecast 2023-2028
o Exhibit 56: Chart on Clinics and others - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Clinics and others - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Clinics and others - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Clinics and others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ million)
o Exhibit 61: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.11 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 bioMerieux SA
o Exhibit 111: bioMerieux SA - Overview
o Exhibit 112: bioMerieux SA - Product / Service
o Exhibit 113: bioMerieux SA - Key news
o Exhibit 114: bioMerieux SA - Key offerings
o 12.4 Cardinal Health Inc.
o Exhibit 115: Cardinal Health Inc. - Overview
o Exhibit 116: Cardinal Health Inc. - Business segments
o Exhibit 117: Cardinal Health Inc. - Key news
o Exhibit 118: Cardinal Health Inc. - Key offerings
o Exhibit 119: Cardinal Health Inc. - Segment focus
o 12.5 Cenogenics Corp.
o Exhibit 120: Cenogenics Corp. - Overview
o Exhibit 121: Cenogenics Corp. - Product / Service
o Exhibit 122: Cenogenics Corp. - Key offerings
o 12.6 CTK Biotech Inc.
o Exhibit 123: CTK Biotech Inc. - Overview
o Exhibit 124: CTK Biotech Inc. - Product / Service
o Exhibit 125: CTK Biotech Inc. - Key offerings
o 12.7 Danaher Corp.
o Exhibit 126: Danaher Corp. - Overview
o Exhibit 127: Danaher Corp. - Business segments
o Exhibit 128: Danaher Corp. - Key news
o Exhibit 129: Danaher Corp. - Key offerings
o Exhibit 130: Danaher Corp. - Segment focus
o 12.8 DiaSorin SpA
o Exhibit 131: DiaSorin SpA - Overview
o Exhibit 132: DiaSorin SpA - Business segments
o Exhibit 133: DiaSorin SpA - Key news
o Exhibit 134: DiaSorin SpA - Key offerings
o Exhibit 135: DiaSorin SpA - Segment focus
o 12.9 Eiken Chemical Co. Ltd.
o Exhibit 136: Eiken Chemical Co. Ltd. - Overview
o Exhibit 137: Eiken Chemical Co. Ltd. - Product / Service
o Exhibit 138: Eiken Chemical Co. Ltd. - Key offerings
o 12.10 Epitope Diagnostics Inc.
o Exhibit 139: Epitope Diagnostics Inc. - Overview
o Exhibit 140: Epitope Diagnostics Inc. - Product / Service
o Exhibit 141: Epitope Diagnostics Inc. - Key offerings
o 12.11 Genova Diagnostics Inc.
o Exhibit 142: Genova Diagnostics Inc. - Overview
o Exhibit 143: Genova Diagnostics Inc. - Product / Service
o Exhibit 144: Genova Diagnostics Inc. - Key offerings
o 12.12 Helena Laboratories Corp.
o Exhibit 145: Helena Laboratories Corp. - Overview
o Exhibit 146: Helena Laboratories Corp. - Product / Service
o Exhibit 147: Helena Laboratories Corp. - Key offerings
o 12.13 Hologic Inc.
o Exhibit 148: Hologic Inc. - Overview
o Exhibit 149: Hologic Inc. - Business segments
o Exhibit 150: Hologic Inc. - Key news
o Exhibit 151: Hologic Inc. - Key offerings
o Exhibit 152: Hologic Inc. - Segment focus
o 12.14 McKesson Corp.
o Exhibit 153: McKesson Corp. - Overview
o Exhibit 154: McKesson Corp. - Business segments
o Exhibit 155: McKesson Corp. - Key offerings
o Exhibit 156: McKesson Corp. - Segment focus
o 12.15 Meridian Bioscience Inc.
o Exhibit 157: Meridian Bioscience Inc. - Overview
o Exhibit 158: Meridian Bioscience Inc. - Business segments
o Exhibit 159: Meridian Bioscience Inc. - Key offerings
o Exhibit 160: Meridian Bioscience Inc. - Segment focus
o 12.16 Quidelortho Corp.
o Exhibit 161: Quidelortho Corp. - Overview
o Exhibit 162: Quidelortho Corp. - Product / Service
o Exhibit 163: Quidelortho Corp. - Key offerings
o 12.17 ScheBo Biotech AG
o Exhibit 164: ScheBo Biotech AG - Overview
o Exhibit 165: ScheBo Biotech AG - Product / Service
o Exhibit 166: ScheBo Biotech AG - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global stool testing market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on GI - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on GI - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on GI - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on GI - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Fecal occult - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Fecal occult - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Fecal occult - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Fecal occult - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on End-user - Market share 2023-2028 (%)
Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Diagnostic centres and laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Diagnostic centres and laboratories - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Clinics and others - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Clinics and others - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Clinics and others - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Clinics and others - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: bioMerieux SA - Overview
Exhibits112: bioMerieux SA - Product / Service
Exhibits113: bioMerieux SA - Key news
Exhibits114: bioMerieux SA - Key offerings
Exhibits115: Cardinal Health Inc. - Overview
Exhibits116: Cardinal Health Inc. - Business segments
Exhibits117: Cardinal Health Inc. - Key news
Exhibits118: Cardinal Health Inc. - Key offerings
Exhibits119: Cardinal Health Inc. - Segment focus
Exhibits120: Cenogenics Corp. - Overview
Exhibits121: Cenogenics Corp. - Product / Service
Exhibits122: Cenogenics Corp. - Key offerings
Exhibits123: CTK Biotech Inc. - Overview
Exhibits124: CTK Biotech Inc. - Product / Service
Exhibits125: CTK Biotech Inc. - Key offerings
Exhibits126: Danaher Corp. - Overview
Exhibits127: Danaher Corp. - Business segments
Exhibits128: Danaher Corp. - Key news
Exhibits129: Danaher Corp. - Key offerings
Exhibits130: Danaher Corp. - Segment focus
Exhibits131: DiaSorin SpA - Overview
Exhibits132: DiaSorin SpA - Business segments
Exhibits133: DiaSorin SpA - Key news
Exhibits134: DiaSorin SpA - Key offerings
Exhibits135: DiaSorin SpA - Segment focus
Exhibits136: Eiken Chemical Co. Ltd. - Overview
Exhibits137: Eiken Chemical Co. Ltd. - Product / Service
Exhibits138: Eiken Chemical Co. Ltd. - Key offerings
Exhibits139: Epitope Diagnostics Inc. - Overview
Exhibits140: Epitope Diagnostics Inc. - Product / Service
Exhibits141: Epitope Diagnostics Inc. - Key offerings
Exhibits142: Genova Diagnostics Inc. - Overview
Exhibits143: Genova Diagnostics Inc. - Product / Service
Exhibits144: Genova Diagnostics Inc. - Key offerings
Exhibits145: Helena Laboratories Corp. - Overview
Exhibits146: Helena Laboratories Corp. - Product / Service
Exhibits147: Helena Laboratories Corp. - Key offerings
Exhibits148: Hologic Inc. - Overview
Exhibits149: Hologic Inc. - Business segments
Exhibits150: Hologic Inc. - Key news
Exhibits151: Hologic Inc. - Key offerings
Exhibits152: Hologic Inc. - Segment focus
Exhibits153: McKesson Corp. - Overview
Exhibits154: McKesson Corp. - Business segments
Exhibits155: McKesson Corp. - Key offerings
Exhibits156: McKesson Corp. - Segment focus
Exhibits157: Meridian Bioscience Inc. - Overview
Exhibits158: Meridian Bioscience Inc. - Business segments
Exhibits159: Meridian Bioscience Inc. - Key offerings
Exhibits160: Meridian Bioscience Inc. - Segment focus
Exhibits161: Quidelortho Corp. - Overview
Exhibits162: Quidelortho Corp. - Product / Service
Exhibits163: Quidelortho Corp. - Key offerings
Exhibits164: ScheBo Biotech AG - Overview
Exhibits165: ScheBo Biotech AG - Product / Service
Exhibits166: ScheBo Biotech AG - Key offerings
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations

ページTOPに戻る

Table of Contents

Summary

Global Stool Testing Market 2024-2028
The stool testing market is forecasted to grow by USD 445.95 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the stool testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by favorable initiatives and the increasing prevalence of gastrointestinal diseases, increasing guidelines from healthcare organizations, and increasing prevalence of CRC.
Technavio's stool testing market is segmented as below:
By Type
• GI
• Fecal occult
By End-user
• Hospitals
• Diagnostic centres and laboratories
• Clinics and others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the high growth potential in emerging markets as one of the prime reasons driving the stool testing market growth during the next few years. Also, growing demand for point-of-care testing and technological advances in fecal occult tests for CRC screening will lead to sizable demand in the market.
The report on the stool testing market covers the following areas:
• Stool testing market sizing
• Stool testing market forecast
• Stool testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stool testing market vendors that include AdvaCare Pharma, bioMerieux SA, Cardinal Health Inc., Cenogenics Corp., Danaher Corp., DiaSorin SpA, Eiken Chemical Co. Ltd., Epitope Diagnostics Inc., Exact Sciences Corp., Genova Diagnostics Inc., Helena Laboratories Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP LLC, Quest Diagnostics Inc., Quidelortho Corp., CTK Biotech Inc., and ScheBo Biotech AG. Also, the stool testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/stool-testing-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

TechNavio社のHealth Care分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

TechNavio社はどのような調査会社ですか?

テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

便検査の世界市場 2024-2028

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

TechNavio社のHealth Care分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

TechNavio社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?